Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of HSK31858 in patients with bronchial asthma
CTR20243603Phase 2Active
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HSK31858 in asthma, sponsored by Haisco Pharmaceutical Group Co., Ltd.. Started Dec 2024; status: active.
02
Drugs
HSK31858
03
Conditions
asthma
Beyond the preview
Go deeper on CTR20243603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243603.